Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
Condition(s):Major Depressive Disorder; Menopausal Staging and Vasomotor Symptoms (for Females)Last Updated:February 8, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Major Depressive Disorder; Menopausal Staging and Vasomotor Symptoms (for Females)Last Updated:February 8, 2012Unknown status
Condition(s):Vascular DepressionLast Updated:March 19, 2015Unknown status
Condition(s):HealthyLast Updated:January 29, 2013Completed
Condition(s):Major Depressive DisorderLast Updated:November 9, 2018Completed
Condition(s):Hot Flashes; Breast NeoplasmsLast Updated:September 20, 2019Terminated
Condition(s):Major Depressive DisorderLast Updated:January 4, 2018Completed
Condition(s):Depression; Opioid Dependence; Methadone TreatmentLast Updated:October 23, 2020Completed
Condition(s):Major Depressive Disorder; Vasomotor SymptomsLast Updated:January 18, 2016Terminated
Condition(s):Major Depressive DisorderLast Updated:January 20, 2014Completed
Condition(s):AnhedoniaLast Updated:February 21, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.